Schirmacher P - Search Results

1

Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.

Singer S, Zhao R, Barsotti AM, Ouwehand A, Fazollahi M, Coutavas E, Breuhahn K, Neumann O, Longerich T, Pusterla T, Powers MA, Giles KM, Leedman PJ, Hess J, Grunwald D, Bussemaker HJ, Singer RH, Schirmacher P, Prives C. Singer S, et al. Among authors: schirmacher p. Mol Cell. 2012 Dec 14;48(5):799-810. doi: 10.1016/j.molcel.2012.09.020. Epub 2012 Oct 24. Mol Cell. 2012. PMID: 23102701 Free PMC article.

2

Molecular pathogenesis of human hepatocellular carcinoma.

Kern MA, Breuhahn K, Schirmacher P. Kern MA, et al. Among authors: schirmacher p. Adv Cancer Res. 2002;86:67-112. doi: 10.1016/s0065-230x(02)86003-1. Adv Cancer Res. 2002. PMID: 12374281 Review. No abstract available.

3

Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.

Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P. Prange W, et al. Among authors: schirmacher p. J Pathol. 2003 Oct;201(2):250-9. doi: 10.1002/path.1448. J Pathol. 2003. PMID: 14517842

4

Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.

Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB, Schirmacher P. Breuhahn K, et al. Among authors: schirmacher p. Cancer Res. 2004 Sep 1;64(17):6058-64. doi: 10.1158/0008-5472.CAN-04-0292. Cancer Res. 2004. PMID: 15342387

5

Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma.

Longerich T, Breuhahn K, Odenthal M, Petmecky K, Schirmacher P. Longerich T, et al. Among authors: schirmacher p. Virchows Arch. 2004 Dec;445(6):589-96. doi: 10.1007/s00428-004-1118-x. Epub 2004 Sep 29. Virchows Arch. 2004. PMID: 15455231

6

Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: effects of cyclooxygenase-2 inhibition in hepatocellular carcinoma.

Kern MA, Haugg AM, Eiteneuer E, Konze E, Drebber U, Dienes HP, Breuhahn K, Schirmacher P, Kasper HU. Kern MA, et al. Among authors: schirmacher p. Liver Int. 2006 Jun;26(5):604-12. doi: 10.1111/j.1478-3231.2006.01268.x. Liver Int. 2006. PMID: 16762006

7

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

Breuhahn K, Longerich T, Schirmacher P. Breuhahn K, et al. Among authors: schirmacher p. Oncogene. 2006 Jun 26;25(27):3787-800. doi: 10.1038/sj.onc.1209556. Oncogene. 2006. PMID: 16799620 Review.

8

Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases.

Knoess M, Kurz AK, Goreva O, Bektas N, Breuhahn K, Odenthal M, Schirmacher P, Dienes HP, Bock CT, Zentgraf H, zur Hausen A. Knoess M, et al. Among authors: schirmacher p. World J Gastroenterol. 2006 Sep 28;12(36):5870-4. doi: 10.3748/wjg.v12.i36.5870. World J Gastroenterol. 2006. PMID: 17007055 Free PMC article.

9

General aspects and pitfalls in liver transplant pathology.

Longerich T, Schirmacher P. Longerich T, et al. Among authors: schirmacher p. Clin Transplant. 2006;20 Suppl 17:60-8. doi: 10.1111/j.1399-0012.2006.00602.x. Clin Transplant. 2006. PMID: 17100703 Review.

10

[Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

Kern MA, Breuhahn K, Schuchmann M, Schirmacher P. Kern MA, et al. Among authors: schirmacher p. Pathologe. 2007 Jul;28(4):261-8. doi: 10.1007/s00292-007-0890-1. Pathologe. 2007. PMID: 17605064 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

848 results

Search Page